We observed restoration of synaptophysin and PSD‐95 immunoreactivity in the AD brain after treatment with either hNSC‐ or iMGL‐derived EVs, indicating a comparable neuroprotective effect in vivo. The gene discussed is DLG4; the disease is Alzheimer disease.